Tezosentan normalizes hepatomesenteric perfusion in a porcine model of cardiac tamponade

Acta Anaesthesiologica Scandinavica

Volumn 53, Issue 2, 2009, Pages 203-209

  Aneman A ^a   Treggiari, M M ^b   Burgener, D ^c   Laesser, M ^a   Strasser, S ^c   Hadengue, A ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; LACTIC ACID; OXYGEN; TEZOSENTAN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART OUTPUT; HEART TAMPONADE; HEMODYNAMICS; HEPATIC ARTERY; LIVER BLOOD FLOW; LIVER PROTECTION; MALE; MESENTERIC ARTERY; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PERFUSION; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; SWINE; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; CARBON DIOXIDE; CARDIAC OUTPUT, LOW; CARDIAC TAMPONADE; DRUG EVALUATION, PRECLINICAL; ENDOTHELIN-1; FEMALE; LACTATES; LIVER CIRCULATION; MALE; MODELS, ANIMAL; OXYGEN; OXYGEN CONSUMPTION; PYRIDINES; RECEPTORS, ENDOTHELIN; SPLANCHNIC CIRCULATION; SUS SCROFA; TETRAZOLES; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 58749091616     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01834.x     Document Type: Article

References (29)

1. Ortega Mateo A, de Artinano AA. Highlights on endothelins: a review. Pharmacol Res 1997 36 : 339 51.
2. Kamoun WS, Shin MC, Karaa A, Clemens MG. Quantification of hepatic microcirculation heterogeneity of perfusion: effects of endothelin-1. Microvas Res 2005 69 : 180 6.
3. Baveja R, Kresge N, Ashburn JH, Keller S, Yokoyama Y, Sonin N, Zhang JX, Huynh T, Clemens MG. Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock 2002 18 : 415 22.
4. Pannen BH, Schroll S, Loop T, Bauer M, Hoetzel A, Geiger KK. Hemorrhagic shock primes the hepatic portal circulation for the vasoconstrictive effects of endothelin-1. Am J Physiol Heart Circ Physiol 2001 281 : H1075 84.
5. Urbanowicz W, Sogni P, Moreau R, Tazi KA, Barriere E, Poirel O, Martin A, Guimont MC, Cazals-Hatem D, Lebrec D. Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats. Gut 2004 53 : 1844 9.
6. Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 2003 31 : 203 10.
7. Iskit AB, Senel I, Sokmensuer C, Guc MO. Endothelin receptor antagonist bosentan improves survival in a murine caecal ligation and puncture model of septic shock. Eur J Pharmacol 2004 506 : 83 8.
8. Burgener D, Laesser M, Treggiari-Venzi M, Oi Y, Jolliet P, Strasser S, Hadengue A, Åneman A. Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model. Crit Care Med 2001 29 : 1615 20.
9. White LR, Juul R, Skaanes KO, Aasly J. Cytokine enhancement of endothelin ET(B) receptor-mediated contraction in human temporal artery. Eur J Pharmacol 2000 406 : 117 22.
10. Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987 7 : 952 63.
11. McMurray JJV, Teerlink JR, Gotter G, Bourge RC, Cleland JGF, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsey J, Frey A, Rainisio M, Kobria I for the VERITAS Investigators. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure. The VERITAS randomized controlled trials. JAMA 2007 298 : 2009 19.
12. Sakata C, Tanaka H, Takemura S, Minamiyama Y, Nakamura A, Katsuragi K, Huang H, Kubo S, Hirohashi K, Kinoshita H. Effect of intraportal infusion of adenosine on hepatic blood flow and injury after ischemia and reperfusion of canine liver. Transplant Proc 1999 31 : 509 10.
13. Jakob SM, Tenhunen JJ, Laitinen S, Heino A, Alhava E, Takala J. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol 2001 280 : G819 27.
14. Pannen BH, Bauer M. Differential regulation of hepatic arterial and portal venous vascular resistance by nitric oxide and carbon monoxide in rats. Life Sci 1998 62 : 2025 33.
15. Ott MC, Scott JR, Bihari A, Badhwar A, Otterbein LE, Gray DK, Harris KA, Potter RF. Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion. FASEB J 2005 19 : 106 8.
16. Wunder C, Brock RW, Frantz S, Göttsch W, Morawietz H, Roewer N, Eichelbrönner O. Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation. Crit Care Med 2005 33 : 2323 31.
17. Rockey DC. Characterization of endothelin receptors mediating rat hepatic stellate cell contraction. Biochem Biophys Res Commun 1995 207 : 725 31.
18. Schlichting E, Aspelin T, Grotmol T, Lyberg T. Endothelin and hemodynamic responses to superior mesenteric artery occlusion shock and hemorrhagic shock in pigs. Shock 1995 3 : 109 15.
19. Eakes AT, Howard KM, Miller JE, Olson MS. Endothelin-1 production by hepatic endothelial cells: characterization and augmentation by endotoxin exposure. Am J Physiol 1997 272 : G605 11.
20. Diamantis I, Van de Casteele M, Hurni B, Reichen J. Detection of endothelin-1 and its receptors in rat liver endothelial cells by in situ reverse transcriptase-polymerase chain reaction. J Hepatol 1998 28 : 157 60.
21. Higuchi H, Satoh T. Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ET(B) receptors in isolated perfused rat liver. Eur J Pharmacol 1997 328 : 175 82.
22. Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, Okumura S, Kashiwagi T, Fusamoto H. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994 19 : 675 81.
23. Reichen J, Gerbes AL, Steiner MJ, Sagesser H, Clozel M. The effect of endothelin and its antagonist bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver. J Hepatol 1998 28 : 1020 30.
24. Yamanaka N, Takaya Y, Oriyama T, Furukawa K, Tanaka T, Tanaka W, Ichikawa N, Yasui C, Ando T, Yamanaka J, Kuroda N, Ko M, Takada M, Imakita M, Kitayama Y, Okamoto E, Sasaki S, Nakagaki I, Hori S, Ito T. Hepatoprotective effect of a nonselective endothelin receptor antagonist (TAK-044) in the transplanted liver. J Surg Res 1997 70 : 156 60.
25. Mitsuoka H, Suzuki S, Sakaguchi T, Baba S, Miwa M, Konno H, Nakamurra S. Contribution of endothelin-1 to microcirculatory impairment in total hepatic ischemia and reperfusion injury. Transplantation 1999 67 : 514 20.
26. Ruetten H, Thiemermann C. Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat. Br J Pharmacol 1996 119 : 479 86.
27. Dhar DK, Yamanoi A, Ohmori H, Nakashima Y, Yamamoto A, Osama NE, Kubota H, Kohno H, Nagasue N. Modulation of endothelin and nitric oxide: a rational approach to improve canine hepatic microcirculation. Hepatology 1998 28 : 782 8.
28. Bracht H, Takala J, Tenhunen JJ, Brander L, Knuesel R, Merasto-Minkkinen M, Jakob SM. Hepatosplanchnic blood flow control and oxygen extraction are modified by the underlying mechanism of impaired perfusion. Crit Care Med 2005 33 : 645 53.
29. Baveja R, Zhang JX, Clemens MG. In vivo assessment of endothelin-induced heterogeneity of hepatic tissue perfusion. Shock 2001 15 : 186 92.